Literature DB >> 22201844

Immune and non-immune functions of the immunoproteasome.

Arkhjamil Angeles1, Gabriel Fung, Honglin Luo.   

Abstract

The biological importance of the ubiquitin-proteasome system in the control of myriad cellular processes has been well-recognized; however, the pathophysiological significance of the immunoproteasome, the inducible form of the proteasome, has not been well-comprehended until lately. The primary function of the immunoproteasome was originally believed to improve MHC-I antigen presentation. It now becomes evident that the immunoproteasome possesses broader biological functions. It regulates proinflammatory cytokine production, and T cell differentiation and proliferation. Alongside immune functions, the immunoproteasome has been demonstrated to relieve oxidative stress by the efficient turnover of oxidatively-damaged proteins and by allaying the formation of harmful protein aggregates. Furthermore, it has been implicated to regulate tumor cell growth and control muscle mass. Finally, the immunoproteasome has recently drawn considerable attention as a potential novel therapeutic target for cancer and autoimmune disease. This review will give an overview of the structure and function of the immunoproteasome, highlight its functional diversity in both immune and non-immune responses, and discuss the relationship between the dysregulation of the immunoproteasome and the development of several human diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201844     DOI: 10.2741/4027

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  43 in total

1.  Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathway.

Authors:  Eun Ryoung Jang; Na-Ra Lee; Songhee Han; Ying Wu; Lalit Kumar Sharma; Kimberly Cornish Carmony; James Marks; Do-Min Lee; Jung-Ok Ban; Marie Wehenkel; Jin Tae Hong; Kyung Bo Kim; Wooin Lee
Journal:  Mol Biosyst       Date:  2012-06-22

Review 2.  The Proteasome and Oxidative Stress in Alzheimer's Disease.

Authors:  Vicent Bonet-Costa; Laura Corrales-Diaz Pomatto; Kelvin J A Davies
Journal:  Antioxid Redox Signal       Date:  2016-08-25       Impact factor: 8.401

3.  Palau'amine and related oroidin alkaloids dibromophakellin and dibromophakellstatin inhibit the human 20S proteasome.

Authors:  Theresa A Lansdell; Nicole M Hewlett; Amanda P Skoumbourdis; Matthew D Fodor; Ian B Seiple; Shun Su; Phil S Baran; Ken S Feldman; Jetze J Tepe
Journal:  J Nat Prod       Date:  2012-05-16       Impact factor: 4.050

4.  Immunoproteasome deficiency in non-small cell lung cancer and its relevance to immunotherapy.

Authors:  Juergen Kast
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 5.  Dysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular disease.

Authors:  Feilong Wang; Amir Lerman; Joerg Herrmann
Journal:  Am J Cardiovasc Dis       Date:  2015-03-10

Review 6.  Expanding proteostasis by membrane trafficking networks.

Authors:  Darren M Hutt; William E Balch
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

7.  Activity-based near-infrared fluorescent probe for LMP7: a chemical proteomics tool for the immunoproteasome in living cells.

Authors:  Lalit Kumar Sharma; Na-Ra Lee; Eun Ryoung Jang; Beilei Lei; Chang-Guo Zhan; Wooin Lee; Kyung-Bo Kim
Journal:  Chembiochem       Date:  2012-07-17       Impact factor: 3.164

Review 8.  Emerging role of immunoproteasomes in pathophysiology.

Authors:  Gagandeep Kaur; Sanjay Batra
Journal:  Immunol Cell Biol       Date:  2016-06-14       Impact factor: 5.126

Review 9.  Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.

Authors:  Q Ping Dou; Jeffrey A Zonder
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

Review 10.  Activity-based imaging probes of the proteasome.

Authors:  Kimberly Cornish Carmony; Kyung Bo Kim
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.